Dominic SchmidtPartner at Syncona Investment Management Ltd., UK
Dominic is a Partner of Syncona. He is a Director and closely involved with the Syncona companies Anaveon and Gyroscope and also served as an observer on the Board of Freeline prior to its NASDAQ IPO. Before joining Syncona, Dominic worked in the life science practice of strategy consultancy L.E.K Consulting. He received his PhD from the Department of Oncology at the University of Cambridge where he was a Cancer Research UK scholar. He also holds a German Diplom Degree in Biochemistry and his research has been honoured with national and international prizes and published in Cell, Nature and Science.